| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a945123f05c2820c5a0f35af735e753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dac000aa57b753adec9feaea5e06602c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5adbe79d2bb1ff6bd722f0cf0ab78d23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbcce21e02d19bb1d1450e674042c947
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4198ef5ecbf92e54a8c4875060225767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5da23730ae43f9ac6bc5f0a4d429e3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-232 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202 |
| filingDate |
2012-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_410e09ca07bd06dc804c0cccbfe47be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7cbb537f3853d90950675bb277522ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c98bdcbb9f8589e84fe210e169d120
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3113816121c638fe6f1f2b8c5faa196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05551b77122bc8b2484be0b209796caa |
| publicationDate |
2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012302639-A1 |
| titleOfInvention |
Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death |
| abstract |
A formulation for treating omega-3 fatty acid deficiency is disclosed containing about 90% or more omega 3 fatty acids by weight comprised of a combination of Eicosapentaenoic acid (EPA), Docosapentaenoic acid (DPA) and Docosahexaenoic acid (DHA) in a weight ratio of EPA:DHA of from 5.7 to 6.3, wherein the sum of the EPA, DHA and DPA comprise about 82% by weight of the total formulation and about 92% of the total omega 3 fatty acid content of the composition. EPA+DHA are about 80% of the total formulation and about 89% of the total omega 3 fatty acid content of the composition. The formulation may further contain specific amounts of arachidonic acid (AA) and of omega-3 fatty acids having 18 carbon atoms, including one or more of stearidonic acid (SDA) and alpha-linolenic acid (ALA). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906964-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015258050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014158256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014143272-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058521-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014134053-A1 |
| priorityDate |
2011-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |